This research was focused on women with polycystic ovarian syndrome (PCOS), a condition that can lower your bodys response to insulin
The shift matters because oral GLP-1 weight loss options have the potential to reach millions of patients who have been reluctant to start, or unable to maintain, injectable therapy
Normally, eating, especially calorie-dense or highly palatable food, triggers the release of dopamine, a neurotransmitter associated with reward and motivation
Weekly injections, ongoing monitoring, and the need to manage side effects can become burdensome over time
For example, co-morbid conditions like hyperlipidemia could tip the scale and make one drug more suitable for a specific patient